BackTable / VI / Tool

Child-Pugh Score Calculator

The Child-Pugh Score calculator can be used to quickly assess the severity of cirrhosis, life expectancy, and risk of perioperative abdominal surgery mortality in patients with liver disease. To use this tool, you will need bilirubin, albumin, prothrombin time (INR), ascites, and encephalopathy grade. Each of these measures have corresponding categories in the Child-Pugh Score calculator that give 1, 2, or 3 points. After inputting your values, the calculator will provide the severity of cirrhosis based on Child-Pugh class, life expectancy, and abdominal surgery perioperative mortality rate.

Child-Pugh Score Calculator

Child-Pugh Score Calculator

Bilrubin (Total)

Albumin

INR

Ascites

Encephalopathy

Calculate

Value

Value

Value

Value

Child-Pugh Score Calculator Results

Based on bilirubin, albumin, prothrombin time (INR), ascites, and encephalopathy the Child-Pugh Score calculator puts patients into one of three risk classes:

• Class A (5 to 6 points): Life expectancy is 15-20 years. Perioperative mortality rate is 10%.
• Class B (7 to 9 points): Life expectancy is 4-14 years. Perioperative mortality rate is 30%.
• Class C (10 to 15 points): Life expectancy is 1-3 years. Perioperative mortality rate is 82%.

Clinical Applications of the Child-Pugh Score Calculator

The Child-Pugh Score is commonly used in practice to help guide care decisions related such as elective abdominal surgery or transjugular intrahepatic portosystemic shunt (TIPS).

Child-Pugh Class A patients are generally considered safe candidates for elective surgery.
Child-Pugh Class B patients are at higher risk, but can undergo surgery after medical optimization.
In Child-Pugh Class C patients, elective surgeries are not considered a safe option even after medical optimization.

In Interventional Oncology, Child-Pugh Score can also be useful in determining the appropriate treatment method for hepatocellular carcinoma (HCC). Placing the Child-Pugh Score into the patient’s clinical context, in addition to understanding the goals of treatment and extent of locoregional therapy, can help shape a patient’s individualized HCC treatment plan.

One of the many HCC treatment algorithms that consider Child-Pugh Score can be found here:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4059812/figure/f2-conc-21-e480/

Limitations of the Child-Pugh Score Calculator

The Child-Pugh Score calculator, despite its ease of use, has important limitations. One limitation is that the risk model uses low-resolution cut-off values in scoring. There is no evidence that these cut-off values define significant changes in mortality, so a small change in value can disproportionately modify the mortality risk determined by the Child-Pugh Score. Another limitation is that some of the variables in the calculator are based on subjective factors. Specifically, subjective interpretation of ascites and encephalopathy may yield different assessments. A third limitation is that Child-Pugh does not consider other prognostic factors like renal function. These limitations are mostly accounted for in the MELD calculator, however the MELD score requires a different set of clinical inputs.

Learn more on the BackTable VI Podcast

BackTable is a knowledge resource for physicians by physicians. Get practical advice on Child-Pugh Score Calculator and how to build your practice by listening to the BackTable VI Podcast, reading exclusing BackTable Articles, and following the work of our Contributors.

Pressure-Directed Therapy in Y90
Ep 16 Pressure-Directed Therapy in Y90 with Dr. Charles Nutting and Dr. Nainesh Parikh
00:00 / 01:04

Follow: Subscribe: Sign Up:

References

[1] Durand, F., & Valla, D. (2005). Assessment of the prognosis of cirrhosis: Child–Pugh versus MELD. Journal of Hepatology,42(1). doi:10.1016/j.jhep.2004.11.015
[2] Tsoris, A. (2020, May 17). Use Of The Child Pugh Score In Liver Disease. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK542308/
[3] Molla, N., AlMenieir, N., Simoneau, E., Aljiffry, M., Valenti, D., Metrakos, P., Boucher, L. M., & Hassanain, M. (2014). The role of interventional radiology in the management of hepatocellular carcinoma. Current Oncology, 21(3), e480–e492. https://doi.org/10.3747/co.21.1829

Disclaimer: The Materials available on BackTable.com are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.

Related Podcasts

Microwave Ablation for Liver Lesions with Dr. Driss Raissi on the BackTable VI Podcast)
Road to Becoming a Y90 Authorized User (While in Training!) with Dr. Rakesh Ahuja on the BackTable VI Podcast)
Is Radioembolization a Future Option for Prostate Cancer? with Dr. Sam Mouli on the BackTable VI Podcast)
Targeting the Tumor Microenvironment in HCC with Dr. Terence Gade on the BackTable VI Podcast)
Locoregional Therapies for Bridging to Transplant in HCC with Dr. Alex Kim on the BackTable VI Podcast)
New Tools to Treat Severe Distal Femoropopliteal Disease with Dr. John Rundback on the BackTable VI Podcast)

Articles

Image-guided microwave liver ablation procedure

Ready, Aim, Ablate: Liver Ablation Procedure Techniques

Physician opening microwave liver ablation device to create ablation zones

Ready, Aim, Ablate: Optimizing the Liver Ablation Zone

Hepatocellular carcinoma on CT

HCC Locoregional Therapies for Bridging to Transplant

Hepatocellular carcinoma on angiography

Patient Selection and Treatment of Hepatocellular Carcinoma

Topics

Cirrhosis Condition Overview
Hepatocellular Carcinoma Condition Overview
Liver Ablation Procedure Prep
Liver Disease Condition Overview
Portal Hypertension Condition Overview
TACE Procedure Steps & Treatment